RowanSOM Research Reveals Breakthrough in Detecting Alzheimer’s Disease

Rowan University has created major buzz with top news headlines about the college of osteopathic medicine (COM)’s recent breakthrough in early Alzheimer’s detection. A research team led by Dr. Robert Nagele of Rowan University School of Osteopathic Medicine (RowanSOM) and Durin Technologies, Inc., has developed a blood test that detects an early stage of Alzheimer’s disease with “unparalleled accuracy.” In a recent proof of concept study, the groundbreaking test demonstrated a 100 percent success rate of overall accuracy, sensitivity, and specificity in identifying patients whose mild cognitive impairment (MCI) is caused by Alzheimer’s. The study results are published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.

Dr. Nagele is testing the same technology to diagnose various early-stage neurodegenerative and neoplastic disorders. The findings are also significant because they can assist in creating simpler and less costly interventions. Read more.

Rowan University Awarded $50,000 Innovation Grant for Health Monitoring Sensor

Rowan University also recently received a $50,000 Innovation Grant from the New Jersey Health Foundation (NJHF) and the Nicholson Foundation. The grant was awarded to Wei Xue, PhD, Assistant Professor in the Department of Mechanical Engineering, to create an improved non-invasive wearable sensor for continuous health monitoring. The goal is to produce the technology to collect data like heart rate and respiration rate from patients in real time. Read the full news release.
Inside OME Header
June 2016
Vol. 10, No. 5